Organigram’s Strong Fiscal Growth and Market Leadership

OrganiGram Holdings (TSE:OGI) has released an update.

Pick the best stocks and maximize your portfolio:

Organigram Holdings, a leading cannabis producer, reported a 17.6% growth in recreational sales for fiscal 2024, with net revenue reaching $159.8 million. The company achieved a 37% adjusted gross margin and a significant 55% increase in adjusted EBITDA compared to the previous fiscal year. Following the acquisition of Motif Labs, Organigram became Canada’s largest cannabis company by market share.

For further insights into TSE:OGI stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.